These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 25438492)

  • 1. Slow junctional rhythm, QTc prolongation and transient torsades de-pointes following combined use of Ivabradine, Diltiazem and Ranolazine.
    Mittal SR
    J Assoc Physicians India; 2014 May; 62(5):426-7. PubMed ID: 25438492
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serious QT interval prolongation with ranolazine and amiodarone.
    Tarapués M; Cereza G; Arellano AL; Montané E; Figueras A
    Int J Cardiol; 2014 Mar; 172(1):e60-1. PubMed ID: 24424337
    [No Abstract]   [Full Text] [Related]  

  • 3. [QTc-interval prolongation in therapy with atypical antipsychotics--results of an open, non-randomized survey].
    Finzel M; Fric M; Laux G
    Psychiatr Prax; 2004 Nov; 31 Suppl 1():S178-80. PubMed ID: 15570546
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [QT prolongation and torsade de pointes tachycardia during therapy with maprotiline. Differential diagnostic and therapeutic aspects].
    Lentini S; Rao ML; Schröder R; Lüderitz B; Bauriedel G
    Dtsch Med Wochenschr; 2001 Dec; 126(49):1396-400. PubMed ID: 11740632
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Amisulpride overdose is frequently associated with QT prolongation and torsades de pointes.
    Isbister GK; Balit CR; Macleod D; Duffull SB
    J Clin Psychopharmacol; 2010 Aug; 30(4):391-5. PubMed ID: 20531221
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prolonged QT interval and torsades de pointes associated with atazanavir therapy.
    Ly T; Ruiz ME
    Clin Infect Dis; 2007 Mar; 44(6):e67-8. PubMed ID: 17304444
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Conversion to sinus rhythm].
    Brunckhorst CB
    Praxis (Bern 1994); 2006 Feb; 95(7):247-8. PubMed ID: 16524116
    [No Abstract]   [Full Text] [Related]  

  • 8. Torsades de pointes associated with ziprasidone.
    Heinrich TW; Biblo LA; Schneider J
    Psychosomatics; 2006; 47(3):264-8. PubMed ID: 16684946
    [No Abstract]   [Full Text] [Related]  

  • 9. Fluconazole-associated QT interval prolongation and Torsades de Pointes in a paediatric patient.
    Ünal Yüksekgönül A; Ertuğrul İ; Karagöz T
    Cardiol Young; 2021 Dec; 31(12):2035-2037. PubMed ID: 34024302
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ranolazine-induced Repolarization Changes: A Case Report.
    Kumthekar A; Cossarini F; Shih JC; Taub CC; Massera D
    Am J Med; 2015 Jul; 128(7):e3-5. PubMed ID: 25660248
    [No Abstract]   [Full Text] [Related]  

  • 11. The risk of sudden cardiac death in patients with non-ST elevation acute coronary syndrome and prolonged QTc interval: effect of ranolazine.
    Karwatowska-Prokopczuk E; Wang W; Cheng ML; Zeng D; Schwartz PJ; Belardinelli L
    Europace; 2013 Mar; 15(3):429-36. PubMed ID: 23258816
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diphenhydramine induced QT prolongation and torsade de pointes: An uncommon effect of a common drug.
    Husain Z; Hussain K; Nair R; Steinman R
    Cardiol J; 2010; 17(5):509-11. PubMed ID: 20865683
    [TBL] [Abstract][Full Text] [Related]  

  • 13. QT Interval prolongation and torsades de pointes due to a coadministration of ciprofloxacin and azimilide in a patient with implantable cardioverter-defibrillator.
    Kaźmierczak J; Peregud-Pogorzelska M; Rzeuski R
    Pacing Clin Electrophysiol; 2007 Aug; 30(8):1043-6. PubMed ID: 17669094
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Torsades de pointes induced by the concomitant use of ivabradine and azithromycin: an unexpected dangerous interaction.
    Cocco G; Jerie P
    Cardiovasc Toxicol; 2015 Jan; 15(1):104-6. PubMed ID: 25158669
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A retrospective study of the safety of intramuscular ziprasidone in agitated elderly patients.
    Greco KE; Tune LE; Brown FW; Van Horn WA
    J Clin Psychiatry; 2005 Jul; 66(7):928-9. PubMed ID: 16013910
    [TBL] [Abstract][Full Text] [Related]  

  • 16. QTc prolongation and torsades de pointes associated with methadone therapy.
    Routhier DD; Katz KD; Brooks DE
    J Emerg Med; 2007 Apr; 32(3):275-8. PubMed ID: 17394991
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Citalopram induced torsade de pointes, a rare life threatening side effect.
    Kanjanauthai S; Kanluen T; Chareonthaitawee P
    Int J Cardiol; 2008 Dec; 131(1):e33-4. PubMed ID: 17919753
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Drug-induced prolongation of the QT interval.
    Curigliano G; Cipolla C; de Braud F
    N Engl J Med; 2004 Jun; 350(25):2618-21; author reply 2618-21. PubMed ID: 15208787
    [No Abstract]   [Full Text] [Related]  

  • 19. QT interval prolongation and torsades de pointes due to erythromycin lactobionate.
    Oberg KC; Bauman JL
    Pharmacotherapy; 1995; 15(6):687-92. PubMed ID: 8602374
    [TBL] [Abstract][Full Text] [Related]  

  • 20. QT prolongation and Torsades de Pointes following overdose of ziprasidone and amantadine.
    Manini AF; Raspberry D; Hoffman RS; Nelson LS
    J Med Toxicol; 2007 Dec; 3(4):178-81. PubMed ID: 18072173
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.